425 related articles for article (PubMed ID: 10648469)
1. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
3. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
Ksontini R; Colagiovanni DB; Josephs MD; Edwards CK; Tannahill CL; Solorzano CC; Norman J; Denham W; Clare-Salzler M; MacKay SL; Moldawer LL
J Immunol; 1998 Apr; 160(8):4082-9. PubMed ID: 9558119
[TBL] [Abstract][Full Text] [Related]
4. An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity.
Fiorucci S; Mencarelli A; Palazzetti B; Del Soldato P; Morelli A; Ignarro LJ
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2652-7. PubMed ID: 11226294
[TBL] [Abstract][Full Text] [Related]
5. Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation.
Künstle G; Hentze H; Germann PG; Tiegs G; Meergans T; Wendel A
Hepatology; 1999 Nov; 30(5):1241-51. PubMed ID: 10534346
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice.
Santucci L; Fiorucci S; Cammilleri F; Servillo G; Federici B; Morelli A
Hepatology; 2000 Feb; 31(2):399-406. PubMed ID: 10655263
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
Fiorucci S; Antonelli E; Santucci L; Morelli O; Miglietti M; Federici B; Mannucci R; Del Soldato P; Morelli A
Gastroenterology; 1999 May; 116(5):1089-106. PubMed ID: 10220501
[TBL] [Abstract][Full Text] [Related]
8. IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs.
Fiorucci S; Santucci L; Cirino G; Mencarelli A; Familiari L; Soldato PD; Morelli A
J Immunol; 2000 Nov; 165(9):5245-54. PubMed ID: 11046058
[TBL] [Abstract][Full Text] [Related]
9. A role for caspases in controlling IL-4 expression in T cells.
Sehra S; Patel D; Kusam S; Wang ZY; Chang CH; Dent AL
J Immunol; 2005 Mar; 174(6):3440-6. PubMed ID: 15749878
[TBL] [Abstract][Full Text] [Related]
10. Metformin aggravates immune-mediated liver injury in mice.
Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
[TBL] [Abstract][Full Text] [Related]
11. Induction of CPP32-like activity and inhibition of interleukin 1beta converting enzyme activity in the liver of a mouse concanavalin A-induced hepatitis model.
Okamoto T; Kobayashi T; Tsuzuike N; Hara K
Jpn J Pharmacol; 1998 Jul; 77(3):257-9. PubMed ID: 9717774
[TBL] [Abstract][Full Text] [Related]
12. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.
Chen D; McKallip RJ; Zeytun A; Do Y; Lombard C; Robertson JL; Mak TW; Nagarkatti PS; Nagarkatti M
J Immunol; 2001 May; 166(10):5889-97. PubMed ID: 11342603
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
Fiorucci S; Santucci L; Federici B; Antonelli E; Distrutti E; Morelli O; Renzo GD; Coata G; Cirino G; Soldato PD; Morelli A
Aliment Pharmacol Ther; 1999 Mar; 13(3):421-35. PubMed ID: 10102977
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.
Li M; Liu GT
World J Gastroenterol; 2004 Jun; 10(12):1775-9. PubMed ID: 15188504
[TBL] [Abstract][Full Text] [Related]
15. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis.
Guillot C; Coathalem H; Chetritt J; David A; Lowenstein P; Gilbert E; Tesson L; van Rooijen N; Cuturi MC; Soulillou JP; Anegon I
J Immunol; 2001 Apr; 166(8):5225-35. PubMed ID: 11290807
[TBL] [Abstract][Full Text] [Related]
16. Pro-Th1 cytokines promote Fas-dependent apoptosis of immature peripheral basophils.
Schneider E; Tonanny MB; Lisbonne M; Leite-de-Moraes M; Dy M
J Immunol; 2004 May; 172(9):5262-8. PubMed ID: 15100264
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis.
Tagawa Y; Kakuta S; Iwakura Y
Eur J Immunol; 1998 Dec; 28(12):4105-13. PubMed ID: 9862346
[TBL] [Abstract][Full Text] [Related]
18. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
Kremer M; Hines IN; Milton RJ; Wheeler MD
Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
[TBL] [Abstract][Full Text] [Related]
20. Differential caspase-9-dependent signaling pathway between tumor necrosis factor receptor- and Fas-mediated hepatocyte apoptosis in mice.
Imao M; Nagaki M; Imose M; Moriwaki H
Liver Int; 2006 Feb; 26(1):137-46. PubMed ID: 16420519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
